Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.23−0.03 (-10.27%)
Close on Nov 17, 2026Market cap $3.59MP/E –Yield –
Traws Pharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Traws Pharma's pe ratio was 1.4× on Apr 30, 2026.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Apr 30, 2026 | 1.4× | – |
See a number that looks wrong?